U.S. Paper and Forestry Products Stock News

Karman Holdings (KRMN) is drawing investor attention after recent trading left the stock down about 9% over the past month and about 21% over the past 3 months, despite a 1 year total return above 50%. See our latest analysis for Karman Holdings. The recent share price return shows momentum fading near the latest price of US$64.10, with the stock down over the past quarter even as the 1 year total shareholder return remains strongly positive. If Karman’s moves in space and defense have caught...

Earnings beat, dividend increase and new protein snacks put PepsiCo (PEP) in focus PepsiCo (PEP) has been back in the spotlight after beating recent earnings expectations, reaffirming full year guidance, raising its dividend for the 54th straight year, and rolling out new protein focused snacks and health oriented drinks. See our latest analysis for PepsiCo. PepsiCo’s recent product launches and dividend increase have come alongside mixed price action, with a 1-day share price return of 1.16%...

AbCellera Biologics (ABCL) is back on investors’ radar after early Phase 1 data for its lead program ABCL635 and a fresh quarterly earnings report that shows higher revenue and a smaller net loss. See our latest analysis for AbCellera Biologics. The recent Phase 1 data for ABCL635 and the quarterly update appear to have coincided with a sharp acceleration in momentum, with the stock showing a 27.14% 7 day share price return, a 71.62% 90 day share price return, and a 163.96% 1 year total...

Earlier in May 2026, Nvidia invested US$10.40 million in Generate Biomedicines, an AI-driven biotech now advancing several drug candidates through clinical development, including a Phase 3 severe asthma program and oncology therapies with FDA Fast Track status. This combination of external validation from a major AI leader and visible clinical momentum underscores how AI-enabled drug discovery is moving from concept toward real-world testing. Next, we’ll examine how Nvidia’s investment and...

Bullish recently reported first-quarter 2026 results showing US$20.01 million in sales and a net loss of US$581.71 million, while also announcing a US$4.20 billion acquisition of Equiniti and facing widening per-share losses versus a year earlier. Amid these developments and broader digital asset volatility, ARK Invest and other institutional investors have been actively building positions in Bullish, signaling renewed institutional focus on its role in tokenization and crypto-market...

Ambiq Micro stock: quick context on recent performance Ambiq Micro (AMBQ) has been drawing attention after sharp recent gains, with the stock up 130% over the past month and up about 172% over the past 3 months. That move comes as investors weigh a US$1.75b market value against the company’s US$81.8m in revenue and a reported net loss of US$38.3m from its ultra low power semiconductor business. See our latest analysis for Ambiq Micro. At a share price of US$81.67, Ambiq Micro’s recent surge,...

Intellia Therapeutics (NTLA) recently reported first quarter results showing a net loss of US$96.23 million and basic loss per share of US$0.81, compared with US$114.33 million and US$1.10 a year earlier. See our latest analysis for Intellia Therapeutics. Despite a recent 7 day share price return that declined 7.83% and a 30 day share price return that declined 7.56%, Intellia’s year to date share price return of 36.81% and 1 year total shareholder return of 37.55% suggest momentum has been...

In the first quarter ended March 28, 2026, Netlist, Inc. reported sales of US$104.89 million, up from US$28.98 million a year earlier, and turned a prior net loss of US$9.49 million into net income of US$8.65 million. This shift from loss to profit, alongside higher basic and diluted earnings per share of US$0.03 from continuing operations, highlights a sharp improvement in Netlist’s operating performance over the past year. With this earnings turnaround as a backdrop, we’ll now examine how...

Earlier this week, Columbia Sportswear’s shares reacted to easing Treasury yields and progress in Iran peace talks, as lower rate expectations and reduced inflation concerns supported companies tied to discretionary consumer spending. Valuation metrics now suggest a sizeable margin of safety alongside a strong overall GF Score™, even as insider activity has been limited to modest selling in recent months. We’ll now examine how cooling Treasury yields and the market’s renewed risk appetite...

UGI (UGI) has just completed a US$500 million fixed income offering, issuing 6.875% senior notes due 2031 under Regulation S and Rule 144A. This move puts its capital structure in focus for shareholders. See our latest analysis for UGI. UGI's US$500 million note issue comes as the stock trades at US$35.65, with the share price down 5.3% year to date but supported by a 2.97% one year total shareholder return and a strong 47.65% three year total shareholder return. This suggests that recent...

Ultra Clean Holdings (UCTT) is back on investor radars after a surge in analyst optimism, with Wall Street raising earnings per share estimates and awarding the stock a top Zacks Rank #1 rating. See our latest analysis for Ultra Clean Holdings. The stock’s share price return has been strong over longer periods, with a 90 day share price return of 36.8% and a year to date share price return of 207.5%. The 1 year total shareholder return sits at 321.53%, suggesting momentum that aligns with the...

Recent performance of Permian Basin Royalty Trust (PBT) Permian Basin Royalty Trust (PBT) has drawn fresh attention after a strong stretch for the stock, with returns of 3.4% over the past day, 6.9% over the past week, and 39.4% over the past month. See our latest analysis for Permian Basin Royalty Trust. Set against a 1 year total shareholder return of 181% and a 5 year total shareholder return of roughly 8x, the recent 30 day share price return of 39.4% and year to date share price return...

In May 2026, Diodes Incorporated reported strong first-quarter results, drew positive analyst commentary on its cyclical recovery, and expanded its AH371xQ automotive-compliant Hall effect latch series for low-threshold motor control and position-sensing applications across a wide range of vehicle systems. This combination of earnings momentum and deeper penetration into automotive electronics underscores how Diodes is increasingly tying its product roadmap to long-term content growth in...

Sigma Lithium Corporation reported first-quarter 2026 results with sales of US$42.34 million versus US$47.67 million a year earlier, while net income rose to US$11.13 million from US$4.73 million. Soon after, investor attention shifted to a Brazilian court order requiring the company’s subsidiary to post collateral over alleged environmental damages, bringing legal, financial, and reputational risks into sharper focus. We’ll now examine how the Brazilian court-ordered collateral for alleged...

In mid-May 2026, Encompass Health Corp. completed a US$500,000,000 private offering of 5.875% senior unsecured notes due 2034 and moved to redeem US$400,000,000 of its 4.500% senior notes due 2028 at par, expecting a US$3,200,000 loss on early extinguishment of debt. This refinancing, alongside plans for a new 50-bed inpatient rehabilitation hospital in Post Falls, Idaho opening in 2028, reshapes the company’s capital structure while supporting continued expansion of its rehabilitation...

NANO Nuclear Energy (NNE) drew investor focus after the U.S. Nuclear Regulatory Commission accepted the construction permit application for its KRONOS MMR microreactor at the University of Illinois Urbana Champaign, formally starting detailed regulatory review. See our latest analysis for NANO Nuclear Energy. The regulatory milestone has arrived alongside a 1 day share price return of 6.58% and a 7 day share price return of 7.26%. However, the 1 year total shareholder return is down 25.46%,...

Earlier this month, UL Solutions Inc. announced a quarterly dividend of US$0.145 per share payable on June 8, 2026, while also reporting strong first-quarter 2026 results and unveiling AI-powered ULTRUS UL 360 software for product carbon footprint and Scope 3 emissions data management. Alongside reinforcing its role in safety with a public warning about electric scooters bearing unauthorized UL Marks, the company is extending its reach into digital sustainability tools that help customers...

On May 15, 2026, Inspire Medical Systems’ Chief Product and Innovation Officer, John Rondoni, sold 2,641 shares at a weighted average price of US$43.28, and the company cut its 2026 guidance amid reimbursement and coding uncertainty linked to a new Wisconsin MAC directive and the WISER Medicare pilot. This combination of insider selling and heightened concern over Medicare coding and reimbursement for hypoglossal nerve stimulation has sharpened investor focus on Inspire’s earnings visibility...

New York Times (NYT) is back in focus after outlining a push to widen its digital subscription base, including new products for younger readers and sports fans through The Athletic, along with expanded multimedia offerings. See our latest analysis for New York Times. At a share price of US$74.96, New York Times has seen a 7.36% year to date share price return. Its 1 year total shareholder return of 36.89% and 3 year total shareholder return of 115.80% point to momentum built over a longer...

Core Natural Resources, Inc. has promoted Robert Braithwaite to senior vice president and chief commercial officer, giving him oversight of coal sales and marketing, transportation and logistics, and commercial strategy across domestic and international markets as of May 13, 2026. Alongside this leadership expansion, Core’s subsidiary Touchstone Advanced Composites has been selected to supply structural tooling and components for Northrop Grumman’s YFQ-48A Talon Blue Autonomous Wingman...

Earlier in May 2026, AeroVironment expanded its AV_Halo mission software with the INSTINCT autonomy framework and DETECT RF sensing suite, while also winning a three-year, US$43 million PANTHER antenna integration contract on Department of War SkyRange test platforms. Together, these software and telemetry advances deepen AeroVironment’s role in autonomous, multi-domain defense operations and high-end weapons testing infrastructure, reinforcing its push into modular, AI-enabled mission...

Earlier in May 2026, Xenon Pharmaceuticals reported stronger-than-expected Q1 results, with its X-TOLE2 study of azetukalner in focal onset seizures exceeding internal expectations and supporting plans to submit a New Drug Application to the FDA in Q3 2026. This progress underscores how clinical momentum in azetukalner, supported by extensive trial data, is increasingly central to Xenon’s broader neuroscience ambitions. Next, we’ll explore how Xenon’s X-TOLE2 outperformance and upcoming FDA...

Analyst optimism puts Etsy (ETSY) back on investors’ radar Recent analyst upgrades for Etsy (ETSY), tied to stronger first quarter operating results and improving buyer activity metrics, have pushed the stock into focus again for investors assessing technology driven e commerce platforms. See our latest analysis for Etsy. The recent analyst upgrades and stronger first quarter results sit against a mixed share price backdrop, with a 19.11% 90 day share price return and 31.05% 1 year total...

Cboe Global Markets recently expanded its Dow Jones Industrial Average index (DJX) options suite to include daily expiring contracts, while also affirming a US$0.72 second-quarter 2026 dividend and making several board and senior government-relations leadership changes. The launch of daily DJX options adds another zero-days-to-expiration product to Cboe’s growing index options lineup, aligning with rising demand for short-dated, cash-settled hedging and trading tools. We’ll now examine how...